from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2219/-

LFCtreatmentdescriptionclass of inhibitor

-1.217

Amikacinug/mL Amikacintranslation

-2.143

Cap5-10ug/mL Capreomycintranslation

-2.644

Rox10-50 ug/mL Roxithromycintranslation

-0.236

SM2-5 ug/mL Streptomycintranslation

-0.961

Tet5-10 ug/mL Tetracyclinetranslation

0.861

Rif0.2-5ug/mL Rifampicintranscription

0.225

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.137

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.116

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.838

CPZ10-50 ug/mL Chlorpromazinerespiration

1.031

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.311

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-3.657

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.900

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.570

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.015

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.266

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.270

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.568

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.034

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.669

KCN5-20 ug/mL Potassium cyaniderespiration

0.483

NaN30.2-2 mM Sodium aziderespiration

1.116

Nigericin50 uM Nigericinrespiration

-0.552

TRC10-150 ug/mL Triclosanrespiration

1.310

TRZ10-25 ug/mL Thioridazinerespiration

-2.343

Valinomycin0.5-10 uM Valinomycinrespiration

0.112

ZnSO42 mM ZnSO4respiration

0.887

menadione6-10 ug/mL Menadionerespiration

0.029

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.328

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.566

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.395

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.159

NRP_1Non-replicating persistence stage 1dosRassociated

0.461

Amp0.2mg/mL AmpicillincellWall

-0.368

Cephalexin20-100 ug/mL CephalexincellWall

-0.111

Cerulenin0.32-5 ug/mL CerulenincellWall

0.068

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.236

EMB10-20 ug/mL EthambutolcellWall

0.412

Eta12-40 ug/mL EthionamidecellWall

0.552

INH0.2-0.4 ug/mL IsoniazidcellWall

0.884

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.227

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.674

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.397

BZA0.12 mg/mL BenzamidearomaticAmides

0.297

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.054

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.844

H2O24 mM hydrogen peroxideDNAdamaging

-0.865

Levo10 ug/mL LevofloxacinDNAdamaging

0.261

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.062

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.252

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.108

UVUV-irradiationDNAdamaging

0.155

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.068

Antimycin12.5-50 ug/mL Antimycin A?

-0.357

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.247

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.648

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.234

PA8240.2-2 ug/mL PA-824?

0.762

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.033

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.844

Verapamil50 uM Verapamil?

-0.644

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.585

methoxatin10-20 ug/mL Methoxatin?